Holen Sie sich die Stockscreener-App
1.05
0.00%
0.00
Vorhandelsmarkt:
1.04
-0.01
-0.95%
Schlusskurs vom Vortag:
$1.05
Offen:
$1.06
24-Stunden-Volumen:
80,214
Relative Volume:
0.16
Marktkapitalisierung:
$24.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.33M
KGV:
-1.5909
EPS:
-0.66
Netto-Cashflow:
$-13.21M
1W Leistung:
-2.78%
1M Leistung:
-0.94%
6M Leistung:
+0.96%
1J Leistung:
-22.79%
1-Tages-Spanne:
$1.04
$1.0699
1-Wochen-Bereich:
$1.0286
$1.16
52-Wochen-Spanne:
$0.8101
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Firmenname
Enlivex Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ENLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.05 | 25.51M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-02 | Bestätigt | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Aktie (ENLV) Neueste Nachrichten
Price action breakdown for Enlivex Therapeutics Ltd.Weekly Trade Summary & Weekly High Return Forecasts - newser.com
Comparing Enlivex Therapeutics Ltd. in custom built stock radars2025 Volume Leaders & Growth Focused Entry Reports - newser.com
How Enlivex Therapeutics Ltd. stock reacts to job market data2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Will Enlivex Therapeutics Ltd. stock deliver shareholder value2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
Will Enlivex Therapeutics Ltd. stock maintain dividend yieldJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Detecting price anomalies in Enlivex Therapeutics Ltd. with AIJuly 2025 Action & Weekly Watchlist for Hot Stocks - newser.com
What’s the recovery path for long term holders of Enlivex Therapeutics Ltd.Quarterly Investment Review & Safe Entry Momentum Tips - newser.com
Will Enlivex Therapeutics Ltd. stock gain from strong economyTrade Analysis Summary & Capital Efficiency Focused Strategies - newser.com
Using portfolio simulators with Enlivex Therapeutics Ltd. included2025 Investor Takeaways & Low Volatility Stock Recommendations - newser.com
Why analysts remain bullish on Enlivex Therapeutics Ltd. stockJuly 2025 Closing Moves & Weekly Setup with ROI Potential - newser.com
Can Enlivex Therapeutics Ltd. stock maintain operating marginsMarket Sentiment Review & Entry Point Confirmation Signals - newser.com
Published on: 2025-11-02 22:57:27 - newser.com
Enlivex Therapeutics Ltd. (ENLV) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Backtesting results for Enlivex Therapeutics Ltd. trading strategiesTrade Exit Report & Safe Capital Growth Plans - newser.com
Has Enlivex Therapeutics Ltd. found a price floorEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Technical signs of recovery in Enlivex Therapeutics Ltd.2025 Trade Ideas & Fast Gain Stock Tips - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pocono Record
Why Enlivex Therapeutics Ltd. stock is considered a top pickWatch List & Real-Time Buy Signal Alerts - newser.com
Trend analysis for Enlivex Therapeutics Ltd. this weekTrade Exit Summary & Community Consensus Trade Signals - newser.com
Can Enlivex Therapeutics Ltd. stock deliver consistent earnings growthQuarterly Performance Summary & Technical Pattern Based Signals - newser.com
How to recover losses in Enlivex Therapeutics Ltd. stock2025 Retail Activity & Weekly High Momentum Picks - newser.com
Published on: 2025-10-30 23:36:56 - newser.com
Finanzdaten der Enlivex Therapeutics Ltd-Aktie (ENLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):